Detrusor Underactivity as an HCN-mediated Failure of Resilience in Aging

逼尿肌活动不足是 HCN 介导的衰老过程中弹性丧失的原因

基本信息

项目摘要

ABSTRACT Detrusor Underactivity (DU) is a voiding impairment due to insufficient bladder muscle effort to ensure timely and efficient bladder emptying. As a disorder of volume management, DU is often associated with incontinence and other urinary symptoms, especially in later life. Despite the term suggesting a bladder muscle disorder, a key characteristic of DU is loss of sensitivity to bladder volume. Like DU, aging is also associated with loss of volume sensitivity. Moreover, aging is characterized by increasing risk of failure to adapt to biologic challenge, i.e. loss of resilience. We therefore propose that DU is not a detrusor disease, rather it is a manifestation of the nonresilient end of the spectrum of bladder sensory changes of aging. In this project we will investigate the role of a “pacemaker” ion channel in the age evolution of a control mechanism critical to bladder volume sensitivity. We hypothesize that DU is associated with the more severe age- associated changes. This knowledge will allow us to determine the control factors contributing to the loss of successful, resilient aging and the resulting non-resilience manifested as DU. To accomplish these goals will use our established mouse cystometry model to test urinary resilience and define a DU group separate from age groups. Our research methods will include single cell genomic sequencing, electrophysiology, molecular/cellular investigations, and correlative tissue-level experiments in order to address our objective. By taking advantage of the uniquely available combined expertise within the UConn Center on Aging, Neurosciences department, and on-site Jackson laboratory, we will address the goal of identifying DU pathophysiology and contributing to an improved therapeutic model which recognizes DU as an adaptive failure.
摘要 逼尿肌活动不足(DU)是由于膀胱肌肉努力不足而导致的排尿障碍,以确保及时排尿。 和有效的膀胱排空。作为一种容量管理障碍,DU通常与 尿失禁和其他泌尿系统症状,尤其是在晚年。尽管这个词暗示着膀胱 肌肉紊乱,DU的一个关键特征是对膀胱容量的敏感性丧失。与DU一样,衰老也是 与音量敏感性丧失相关。此外,衰老的特点是失败的风险增加, 适应生物挑战,即丧失复原力。因此,我们认为DU不是逼尿肌疾病, 相反,它是衰老的膀胱感觉变化谱的非弹性端的表现。在这 本计画将探讨“起搏器”离子通道在控制机制年龄演化中的角色 对膀胱容量敏感性至关重要。我们假设DU与更严重的年龄相关- 相关的变化。这一知识将使我们能够确定造成损失的控制因素, 成功的,有弹性的老龄化和由此产生的非弹性表现为DU。为了实现这些目标, 使用我们建立的小鼠膀胱测压模型来测试尿弹性,并将DU组与 年龄组我们的研究方法将包括单细胞基因组测序,电生理学, 分子/细胞研究和相关的组织水平实验,以解决我们的目标。通过 利用康州大学老龄化中心独特的综合专业知识, 神经科学部门,和现场杰克逊实验室,我们将解决的目标,确定杜 病理生理学,并有助于改善治疗模型,认识到DU作为一种适应性 失败

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.
  • DOI:
    10.1002/nau.24649
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Ramasamy R;Smith PP
  • 通讯作者:
    Smith PP
Loss of resilience contributes to detrusor underactivity in advanced age.
  • DOI:
    10.1007/s10522-022-10005-y
  • 发表时间:
    2023-04
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Ramasamy, Ramalakshmi;Baker, Dylan S. S.;Lemtiri-Chlieh, Fouad;Rosenberg, Dawn A. A.;Woon, Eric;Al-Naggar, Iman M. M.;Hardy, Cara C. C.;Levine, Eric S. S.;Kuchel, George A. A.;Bartley, Jenna M. M.;Smith, Phillip P. P.
  • 通讯作者:
    Smith, Phillip P. P.
PART 2: Mouse models for multiple sclerosis research.
  • DOI:
    10.1002/nau.24654
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Ramasamy R;Smith PP
  • 通讯作者:
    Smith PP
Alzheimer's disease amyloidogenesis is linked to altered lower urinary tract physiology.
阿尔茨海默病淀粉样蛋白生成与下尿路生理学改变有关。
  • DOI:
    10.1002/nau.24952
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Hardy,CaraC;Ramasamy,Ramalakshmi;Rosenberg,DawnA;Kuchel,GeorgeA;Yan,Riqiang;Hu,Xiangyou;Smith,PhillipP
  • 通讯作者:
    Smith,PhillipP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE A KUCHEL其他文献

GEORGE A KUCHEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE A KUCHEL', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10376628
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Data Analysis Core
数据分析核心
  • 批准号:
    10376630
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10294029
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Bio-Analysis Core
生物分析核心
  • 批准号:
    10701913
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Data Analysis Core
数据分析核心
  • 批准号:
    10701912
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10701908
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Bio-Analysis Core
生物分析核心
  • 批准号:
    10376631
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10668311
  • 财政年份:
    2021
  • 资助金额:
    $ 57.6万
  • 项目类别:
Role of Senolytics in Lower Urinary Tract Aging and Voiding Disorders
Senolytics 在下尿路老化和排尿障碍中的作用
  • 批准号:
    9765752
  • 财政年份:
    2019
  • 资助金额:
    $ 57.6万
  • 项目类别:
Detrusor Underactivity as an HCN-mediated Failure of Resilience in Aging
逼尿肌活动不足是 HCN 介导的衰老过程中弹性丧失的原因
  • 批准号:
    10341070
  • 财政年份:
    2019
  • 资助金额:
    $ 57.6万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 57.6万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 57.6万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 57.6万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 57.6万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 57.6万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 57.6万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 57.6万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 57.6万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 57.6万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 57.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了